Clinical Benefit of First-Line Cemiplimab in Patients with Locally Advanced NSCLC: Subgroup Analysis from EMPOWER-Lung 1


Bondarenko I., Sezer A., Kilickap S., GÜMÜŞ M., ÖZGÜROĞLU M., Gogishvili M., ...More

JOURNAL OF THORACIC ONCOLOGY, vol.16, no.10, 2021 (SCI-Expanded) identifier

  • Publication Type: Article / Abstract
  • Volume: 16 Issue: 10
  • Publication Date: 2021
  • Journal Name: JOURNAL OF THORACIC ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
  • Keywords: Randomised Controlled Trials, Phase II and III Clinical Trials, Immune checkpoint inhibitors
  • Istanbul University Affiliated: No